Two anaphylactic deaths after chemonucleolysis.
Chemonucleolysis is a procedure for treatment of low back pain due to discogenic disease in which the drug chymopapain is injected into lumbar disks to produce chemical dissolution of the nucleus pulposus. More than 15,000 cases have been treated by chemonucleolysis world-wide. Anaphylaxis after the injection of chymopapain occurs in about 1% of such cases. The two cases described in this paper are the only known deaths due to anaphylaxis. Both patients suddenly became hypotensive after injection of chymopapain into a disk. One patient died shortly after this, whereas the second patient died of the complications of prolonged shock.
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D001344:Autopsy; D001416:Back Pain / Q000188:drug therapy; D002917:Chymopapain / Q000009:adverse effects* / Q000627:therapeutic use; D010450:Endopeptidases / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000188:drug therapy*; D008875:Middle Aged
D010450:Endopeptidases; D002917:Chymopapain